Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Treatment of cells with SSE15206 causes aberrant mitosis resulting in G2/M arrest due to incomplete spindle formation
FC1C=CC(=CC=1)C(C1C=CC(F)=CC=1)N1CCN(C/C=C/C2C=CC=CC=2)CC1
Intracerebroventricularly administered Orexin-A (30 μg/10 μL) blocks the vasopressin (VP) level increase induced by either histamine or 2
Smiles: O=C(NC1N=C2C=CC=C(C3C=CC(CN4CCS(=O)(=O)CC4)=CC=3)N2N=1)C1CC1
Exhibits no detectable binding of VHL
Valacyclovir - CAS# 124832-26-4 a-Naloxol D5 Hydrochloride Treatment of cells with SSE15206Valacyclovir, also known as valacyclovir, is an antiviral drug used in the management of herpes simplex, herpes zoster (shingles), and herpes B. It is a prodrug, being converted in vivo to aciclovir. Valaciclovir has been available as a generic drug in the U. S. since November 25, 2009. Valaciclovir is a prodrug, an esterified version of aciclovir that has greater oral bioavailability (about 55%) than aciclovir (1020%). It is converted by esterases to
US$ 10.39
US$ 20.00
US$ 13.95
US$ 19.95
US$ 15.00
US$ 20.00
US$ 32.99
US$ 32.00
US$ 22.99